The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials

Abstract

These data suggest that the beneficial cardioprotective effects of perindopril treatment are additive to the background beta-blockers use.